These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19412489)

  • 21. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pregabalin with pramipexole for restless legs syndrome.
    Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
    N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute dopamine-agonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability.
    Ferri R; Manconi M; Aricò D; Sagrada C; Zucconi M; Bruni O; Oldani A; Ferini-Strambi L
    Sleep; 2010 Jun; 33(6):793-800. PubMed ID: 20550020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.
    Shinno H; Oka Y; Otsuki M; Tsuchiya S; Mizuno S; Kawada S; Innami T; Sasaki A; Hineno T; Sakamoto T; Inami Y; Nakamura Y; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):522-6. PubMed ID: 20156514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
    Bayard S; Langenier MC; Dauvilliers Y
    Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials.
    Zhang W; Wang Y; Cong SY; Nao JF; Feng J; Bi GR
    Neuropsychiatr Dis Treat; 2013; 9():1035-43. PubMed ID: 23950645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of dopamine receptor agonists in the treatment of restless legs syndrome.
    Happe S; Trenkwalder C
    CNS Drugs; 2004; 18(1):27-36. PubMed ID: 14731057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of restless legs syndrome.
    Comella CL
    Neurotherapeutics; 2014 Jan; 11(1):177-87. PubMed ID: 24363103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restless legs syndrome and its treatment by dopamine agonists.
    Stiasny K; Wetter TC; Trenkwalder C; Oertel WH
    Parkinsonism Relat Disord; 2000 Nov; 7(1):21-25. PubMed ID: 11008192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioids for restless legs syndrome.
    de Oliveira CO; Carvalho LB; Carlos K; Conti C; de Oliveira MM; Prado LB; Prado GF
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD006941. PubMed ID: 27355187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole for the treatment of restless legs syndrome.
    Kushida CA
    Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
    Montplaisir J; Nicolas A; Denesle R; Gomez-Mancilla B
    Neurology; 1999 Mar; 52(5):938-43. PubMed ID: 10102409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of rotigotine in the treatment of restless legs syndrome.
    Serafini A; Lorenzut S; Gigli GL; Merlino G; Valente M
    Ther Adv Neurol Disord; 2010 Jul; 3(4):241-8. PubMed ID: 21179615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the efficacy of pramipexole in patients with restless legs syndrome.
    Rezvani M; Zamani B; Fereshtehnejad SM
    Acta Med Iran; 2013 Jul; 51(6):377-85. PubMed ID: 23852842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.